Cargando…
Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
Autores principales: | Udwadia, Zarir F., Pawar, Unmesha Prakash, Nanda, Viral Jayshinh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746276/ https://www.ncbi.nlm.nih.gov/pubmed/36629242 http://dx.doi.org/10.4103/lungindia.lungindia_355_22 |
Ejemplares similares
-
Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021) -
Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022) -
The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021) -
Clonal Population of Mycobacterium tuberculosis Strains Reside within Multiple Lung Cavities
por: Vadwai, Viral, et al.
Publicado: (2011) -
Post-COVID lung fibrosis: The tsunami that will follow the earthquake
por: Udwadia, Zarir F, et al.
Publicado: (2021)